We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Alpha- Antitrypsin Deficiency Treatment industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
CT-2009
POL-6014
ARO-AAT
ALNAAT-02
Others
Market Segment by Product Application
Clinic
Hospital
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Adverum Biotechnologies, Inc.
Alnylam Pharmaceuticals, Inc.
Applied Genetic Technologies Corporation
Arrowhead Pharmaceuticals, Inc.
Carolus Therapeutics, Inc.
Cevec Pharmaceuticals GmbH
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Editas Medicine, Inc.
Grifols, S.A.
Inhibrx
Intellia Therapeutics, Inc.
International Stem Cell Corporation
Ionis Pharmaceuticals, Inc.
Kamada Ltd.
Polyphor Ltd.
ProMetic Life Sciences Inc.
rEVO Biologics, Inc.
Sangamo BioSciences, Inc.
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Alpha- Antitrypsin Deficiency Treatment consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Alpha- Antitrypsin Deficiency Treatment market by identifying its various subsegments.
3.Focuses on the key global Alpha- Antitrypsin Deficiency Treatment manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Alpha- Antitrypsin Deficiency Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Alpha- Antitrypsin Deficiency Treatment submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Alpha- Antitrypsin Deficiency Treatment Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Alpha- Antitrypsin Deficiency Treatment Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Alpha- Antitrypsin Deficiency Treatment Segment by Type
2.1.1 CT-2009
2.1.2 POL-6014
2.1.3 ARO-AAT
2.1.4 ALNAAT-02
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Clinic
2.2.2 Hospital
2.2.3 Others
2.3 Global Alpha- Antitrypsin Deficiency Treatment Market Comparison by Regions (2017-2027)
2.3.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size (2017-2027)
2.3.2 North America Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2017-2027)
2.3.3 Europe Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2017-2027)
2.3.4 China Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2017-2027)
2.3.5 Japan Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2017-2027)
2.3.6 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Alpha- Antitrypsin Deficiency Treatment Industry Impact
2.5.1 Alpha- Antitrypsin Deficiency Treatment Business Impact Assessment - Covid-19
2.5.2 Market Trends and Alpha- Antitrypsin Deficiency Treatment Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Alpha- Antitrypsin Deficiency Treatment Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Alpha- Antitrypsin Deficiency Treatment Manufacturer Market Share
3.5 Top 10 Alpha- Antitrypsin Deficiency Treatment Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Alpha- Antitrypsin Deficiency Treatment Market
3.7 Key Manufacturers Alpha- Antitrypsin Deficiency Treatment Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Alpha- Antitrypsin Deficiency Treatment Industry Key Manufacturers
4.1 Adverum Biotechnologies, Inc.
4.1.1 Compan Detail
4.1.2 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.1.3 Adverum Biotechnologies, Inc. 161 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Adverum Biotechnologies, Inc. News
4.2 Alnylam Pharmaceuticals, Inc.
4.2.1 Compan Detail
4.2.2 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Adverum Biotechnologies, Inc. News
4.3 Applied Genetic Technologies Corporation
4.3.1 Compan Detail
4.3.2 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Applied Genetic Technologies Corporation News
4.4 Arrowhead Pharmaceuticals, Inc.
4.4.1 Compan Detail
4.4.2 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Arrowhead Pharmaceuticals, Inc. News
4.5 Carolus Therapeutics, Inc.
4.5.1 Compan Detail
4.5.2 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Carolus Therapeutics, Inc. News
4.6 Cevec Pharmaceuticals GmbH
4.6.1 Compan Detail
4.6.2 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Cevec Pharmaceuticals GmbH News
4.7 Dicerna Pharmaceuticals, Inc.
4.7.1 Compan Detail
4.7.2 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Digna Biotech, S.L.
4.8.1 Compan Detail
4.8.2 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Digna Biotech, S.L. News
4.9 Editas Medicine, Inc.
4.9.1 Compan Detail
4.9.2 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Editas Medicine, Inc. News
4.10 Grifols, S.A.
4.10.1 Compan Detail
4.10.2 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Grifols, S.A. News
4.11 Inhibrx
4.11.1 Compan Detail
4.11.2 Inhibrx Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.11.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Inhibrx News
4.12 Intellia Therapeutics, Inc.
4.12.1 Compan Detail
4.12.2 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.12.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Intellia Therapeutics, Inc. News
4.13 International Stem Cell Corporation
4.13.1 Company Details
4.13.2 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.13.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 International Stem Cell Corporation News
4.14 Ionis Pharmaceuticals, Inc.
4.14.1 Compan Detail
4.14.2 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.14.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Ionis Pharmaceuticals, Inc. News
4.15 Kamada Ltd.
4.15.1 Compan Detail
4.15.2 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.15.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Kamada Ltd. News
4.16 Polyphor Ltd.
4.16.1 Compan Detail
4.16.2 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.16.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Polyphor Ltd. News
4.17 ProMetic Life Sciences Inc.
4.17.1 Compan Detail
4.17.2 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.17.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 ProMetic Life Sciences Inc. News
4.18 rEVO Biologics, Inc.
4.18.1 Compan Detail
4.18.2 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.18.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 rEVO Biologics, Inc. News
4.19 Sangamo BioSciences, Inc.
4.19.1 Compan Detail
4.19.2 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
4.19.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 Sangamo BioSciences, Inc. News
5 Global Alpha- Antitrypsin Deficiency Treatment Market Segment by Big Type
5.1 Global Alpha- Antitrypsin Deficiency Treatment Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Big Type (2017-2022)
5.2 CT-2009 Sales Growth Rate and Price
5.2.1 Global CT-2009 Sales Growth Rate (2017-2022)
5.2.2 Global CT-2009 Price (2017-2022)
5.3 POL-6014 Sales Growth Rate and Price
5.3.1 Global POL-6014 Sales Growth Rate (2017-2022)
5.3.2 Global POL-6014 Price (2017-2022)
5.4 ARO-AAT Sales Growth Rate and Price
5.4.1 Global ARO-AAT Sales Growth Rate (2017-2022)
5.4.2 Global ARO-AAT Price (2017-2022)
5.5 ALNAAT-02 Sales Growth Rate and Price
5.5.1 Global ALNAAT-02 Sales Growth Rate (2017-2022)
5.5.2 Global ALNAAT-02 Price (2017-2022)
5.6 Others Sales Growth Rate and Price
5.6.1 Global Others Sales Growth Rate (2017-2022)
5.6.2 Global Others Price (2017-2022)
6 Global Alpha- Antitrypsin Deficiency Treatment Market Segment by Big Application
6.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Big Application (2017-2022)
6.2 Clinic Sales Growth Rate (2017-2022)
6.3 Hospital Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Alpha- Antitrypsin Deficiency Treatment Forecast
7.1 Global Alpha- Antitrypsin Deficiency Treatment Revenue, Sales and Growth Rate (2022-2027)
7.2 Alpha- Antitrypsin Deficiency Treatment Market Forecast by Regions (2022-2027)
7.2.1 North America Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
7.2.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
7.2.3 China Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
7.2.4 Japan Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
7.2.5 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
7.2.6 Other Regions Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
7.3 Alpha- Antitrypsin Deficiency Treatment Market Forecast by Type (2022-2027)
7.3.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Type (2022-2027)
7.3.2 Global Alpha- Antitrypsin Deficiency Treatment Market Share Forecast by Type (2022-2027)
7.4 Alpha- Antitrypsin Deficiency Treatment Market Forecast by Application (2022-2027)
7.4.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Application (2022-2027)
7.4.2 Global Alpha- Antitrypsin Deficiency Treatment Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Alpha- Antitrypsin Deficiency Treatment Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Alpha- Antitrypsin Deficiency Treatment Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Alpha- Antitrypsin Deficiency Treatment
Figure Market Concentration Ratio and Market Maturity Analysis of Alpha- Antitrypsin Deficiency Treatment
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Alpha- Antitrypsin Deficiency Treatment Market Size by Big Type
Figure Global Market Share of Alpha- Antitrypsin Deficiency Treatment by Big Type in 2021
Figure CT-2009 Picture (2017-2022)
Figure POL-6014 Picture (2017-2022)
Figure ARO-AAT Picture (2017-2022)
Figure ALNAAT-02 Picture (2017-2022)
Global Alpha- Antitrypsin Deficiency Treatment Market Size by Big Application
Table Global Alpha- Antitrypsin Deficiency Treatment Market Size by Application
Figure Global Alpha- Antitrypsin Deficiency Treatment Market Share by Big Application in 2021
Figure Clinic Picture
Figure Hospital Picture
Figure Others Picture
Table Global Alpha- Antitrypsin Deficiency Treatment Comparison by Regions (M USD) (2017-2027)
Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size (Million US$) (2017-2027)
Figure North America Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure China Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Alpha- Antitrypsin Deficiency Treatment Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Manufacturer (2017-2022)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2021
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue by Manufacturer (2017-2022)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2021
Table Global Alpha- Antitrypsin Deficiency Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Alpha- Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Alpha- Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Alpha- Antitrypsin Deficiency Treatment Market
Table Key Manufacturers Alpha- Antitrypsin Deficiency Treatment Product Type
Table Mergers & Acquisitions Planning
Table Adverum Biotechnologies, Inc. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Adverum Biotechnologies, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Alnylam Pharmaceuticals, Inc. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Alnylam Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Alnylam Pharmaceuticals, Inc. Recent Development
Table Applied Genetic Technologies Corporation Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Applied Genetic Technologies Corporation
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Applied Genetic Technologies Corporation Main Business
Table Applied Genetic Technologies Corporation Recent Development
Table Arrowhead Pharmaceuticals, Inc. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Arrowhead Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Arrowhead Pharmaceuticals, Inc. Main Business
Table Arrowhead Pharmaceuticals, Inc. Recent Development
Table Arrowhead Pharmaceuticals, Inc. Main Business
Table Arrowhead Pharmaceuticals, Inc. Recent Development
Table Carolus Therapeutics, Inc. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Carolus Therapeutics, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Carolus Therapeutics, Inc. Main Business
Table Carolus Therapeutics, Inc. Recent Development
Table Cevec Pharmaceuticals GmbH Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Cevec Pharmaceuticals GmbH
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cevec Pharmaceuticals GmbH Main Business
Table Cevec Pharmaceuticals GmbH Recent Development
Table Dicerna Pharmaceuticals, Inc. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Dicerna Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dicerna Pharmaceuticals, Inc. Main Business
Table Dicerna Pharmaceuticals, Inc. Recent Development
Table Digna Biotech, S.L. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Digna Biotech, S.L.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Digna Biotech, S.L. Main Business
Table Digna Biotech, S.L. Recent Development
Table Editas Medicine, Inc. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Editas Medicine, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Editas Medicine, Inc. Main Business
Table Editas Medicine, Inc. Recent Development
Table Grifols, S.A. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Grifols, S.A.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Grifols, S.A. Main Business
Table Grifols, S.A. Recent Development
Table Inhibrx Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Inhibrx
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Inhibrx Main Business
Table Inhibrx Recent Development
Table Intellia Therapeutics, Inc. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Intellia Therapeutics, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Intellia Therapeutics, Inc. Main Business
Table Intellia Therapeutics, Inc. Recent Development
Table International Stem Cell Corporation Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of International Stem Cell Corporation
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table International Stem Cell Corporation Main Business
Table International Stem Cell Corporation Recent Development
Table Ionis Pharmaceuticals, Inc. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Ionis Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Ionis Pharmaceuticals, Inc. Main Business
Table Ionis Pharmaceuticals, Inc. Recent Development
Table Polyphor Ltd. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Polyphor Ltd.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Polyphor Ltd. Main Business
Table Polyphor Ltd. Recent Development
Table ProMetic Life Sciences Inc. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of ProMetic Life Sciences Inc.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table ProMetic Life Sciences Inc. Main Business
Table ProMetic Life Sciences Inc. Recent Development
Table rEVO Biologics, Inc. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of rEVO Biologics, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table rEVO Biologics, Inc. Main Business
Table rEVO Biologics, Inc. Recent Development
Table Sangamo BioSciences, Inc. Company Profile
Table Alpha- Antitrypsin Deficiency Treatment Product Introduction, Application and Specification of Sangamo BioSciences, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sangamo BioSciences, Inc. Main Business
Table Sangamo BioSciences, Inc. Recent Development
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2017-2022)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2017-2022)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Regions (2017-2022)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Regions in 2021
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue by Regions (2017-2022)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Regions in 2021
Figure North America Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2017-2022)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2017-2022)
Figure China Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2017-2022)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2017-2022)
Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2017-2022)
Figure Other Regions Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2017-2022)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Big Type (2017-2022)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Big Type (2017-2022)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Big Type in 2019
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue by Big Type (2017-2022)
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Big Type (2017-2022)
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Big Type in 2019
Figure Global CT-2009 Sales Growth Rate (2017-2022)
Figure Global CT-2009 Price (2017-2022)
Figure Global POL-6014 Sales Growth Rate (2017-2022)
Figure Global POL-6014 Price (2017-2022)
Figure Global ARO-AAT Sales Growth Rate (2017-2022)
Figure Global ARO-AAT Price (2017-2022)
Figure Global ALNAAT-02 Sales Growth Rate (2017-2022)
Figure Global ALNAAT-02 Price (2017-2022)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Big Application (2017-2022)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Big Application (2017-2022)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Big Application in 2019
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2022-2027)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2022-2027)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Regions (2022-2027)
Table Global Alpha- Antitrypsin Deficiency Treatment Market Share Forecast by Regions (2022-2027)
Figure North America Sales Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
Figure Europe Sales Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
Figure China Sales Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
Figure Japan Sales Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
Figure Southeast Asia Sales Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
Figure Other Regions Sales Alpha- Antitrypsin Deficiency Treatment Market Forecast (2022-2027)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Type (2022-2027)
Table Global Alpha- Antitrypsin Deficiency Treatment Market Share Forecast by Type (2022-2027)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Application (2022-2027)
Table Global Alpha- Antitrypsin Deficiency Treatment Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alpha- Antitrypsin Deficiency Treatment
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Alpha- Antitrypsin Deficiency Treatment Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Adverum Biotechnologies, Inc.
Alnylam Pharmaceuticals, Inc.
Applied Genetic Technologies Corporation
Arrowhead Pharmaceuticals, Inc.
Carolus Therapeutics, Inc.
Cevec Pharmaceuticals GmbH
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Editas Medicine, Inc.
Grifols, S.A.
Inhibrx
Intellia Therapeutics, Inc.
International Stem Cell Corporation
Ionis Pharmaceuticals, Inc.
Kamada Ltd.
Polyphor Ltd.
ProMetic Life Sciences Inc.
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)